NFKB1 and neoplasm: The anti-proliferative, anti-tumor and anti-leukemic properties have been shown to be mediated via suppression of NF-κB activation and inhibiting the expression of NF-κB regulated genes like lipoxygenase, COX-2, MMP-9, and iNOS [27], [28], [29], [30].